reference/25380709

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25380709

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	216
issn	0887-6924 1476-5551
issueIdentifier	2
pageRange	208-216
publicationName	Leukemia
startingPage	208
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab9fe554b6a0a9bcebfe0e75cbb6083d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_46ff87352526b47f98dadfeafb085420 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3876448d415abe06218b05b449fbd397
bibliographicCitation	Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR. Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study. Leukemia. 2001 Feb;15(2):208–16. doi: 10.1038/sj.leu.2402006. PMID: 11236936.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2abb994537fda4efd27d18cd9caafa64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a183488ec67abeecb287cd6a6503e7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21d2bcb7cd76317321f373b6ef236338 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e99621ce59c618c7f9b8e8f2ea5ad0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c128e8a51065efca53f457a0fcb9c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7b0b846650e4f67bca141a88f2cd697 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce6b41e586589431e34a9ca4d4b16bc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eec83559b9483f643166f130b3f18b50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4244739b845f4474127283932e06dce3
date	200102
identifier	https://doi.org/10.1038/sj.leu.2402006 https://pubmed.ncbi.nlm.nih.gov/11236936
isPartOf	https://portal.issn.org/resource/ISSN/0887-6924 https://portal.issn.org/resource/ISSN/1476-5551 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study
discusses	http://id.nlm.nih.gov/mesh/M0001815 http://id.nlm.nih.gov/mesh/M0013595
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723601 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 62.